Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Amgen    AMGN

AMGEN (AMGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Amgen
Develops, manufactures and markets human therapeutic products based on cellular biology

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses.

The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Its products include aranesp, blincyto, corlanor, enbrel, epogen, imlygic, kyprolis, neulasta, neupogen, nplate, parsab, prolia, repatha, sensipar, vectibix, and xgeva.

The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Number of employees : 19 200 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Product20,94498.2%21,89296.5% +4.53%
Other718.003.4%1,0994.8% +53.06%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States17,16780.5%18,32680.8% +6.75%
Rest of the World4,49521.1%4,66520.6% +3.78%
Managers
NameAgeSinceTitle
Robert Bradway552006Chairman & Chief Executive Officer
Esteban Santos502007Executive Vice President-Operations
David W. Meline, MBA602014Executive VP, Chief Financial & Accounting Officer
Sean E. Harper, PhD552002Executive Vice President-Research & Development
Paul R. Eisenberg, MD-2005Chief Medical Officer & Senior VP-Global Medical
Frank C. Herringer, MBA752004Independent Director
David Baltimore, PhD801999Independent Director
François de Carbonnel722008Independent Director
Rebecca M. Henderson PhD, MBA572009Independent Director
Ronald Sugar692010Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 725,910,575 724,826,079 99.9% 0 0.0% 99.9%
Shareholders
NameEquities%
Fidelity Management & Research Co. 56,581,362 7.79%
Capital Research & Management Co. (Global Investors) 52,482,472 7.23%
The Vanguard Group, Inc. 51,272,773 7.06%
BlackRock Fund Advisors 36,019,836 4.96%
SSgA Funds Management, Inc. 31,944,176 4.40%
PRIMECAP Management Co. 22,259,358 3.07%
Northern Trust Investments, Inc. 9,740,601 1.34%
Morgan Stanley Smith Barney LLC (Private Banking) 8,056,631 1.11%
Geode Capital Management LLC 7,910,295 1.09%
ClearBridge Investments LLC 7,907,099 1.09%
Holdings
NameEquities%Valuation
Atara Biotherapeutics Inc (ATRA) 1,403,5014.59%20,280,589 USD
Cytokinetics, Inc. (CYTK) 1,984,9013.68%17,070,149 USD
Advaxis, Inc. (ADXS) 3,047,4467.42%9,111,864 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  AMGN:US
- Reuters Code :  AMGN.O
- Datastream Code :  @AMGN
Company contact information
Amgen
1 Amgen Center Drive
CA 91320-1799 Thousand Oaks, California
États-Unis (les)

Phone : +1 805 447 1000
Fax : +1 805 447 1010
Internet : http://www.amgen.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
AMGEN6.41%134 322
JOHNSON & JOHNSON4.32%388 981
NOVARTIS1.80%224 968
PFIZER0.88%217 923
ROCHE HOLDING LTD.-0.28%217 905
MERCK AND COMPANY4.25%159 987
SANOFI2.53%113 519
NOVO NORDISK A/S0.61%108 181
BAYER0.83%105 783
BRISTOL-MYERS SQUIBB COMPANY2.50%102 801
ABBOTT LABORATORIES3.10%102 417
ELI LILLY AND COMPANY2.98%95 773
GLAXOSMITHKLINE2.31%92 067
ASTRAZENECA0.21%87 944
CELGENE CORPORATION1.57%83 456
ALLERGAN PLC7.62%58 907
TAKEDA PHARMACEUTICAL CO LTD-1.25%45 913
SHIRE-8.18%44 722
JIANGSU HENGRUI MEDICINE CO LTD8.16%32 531
CHUGAI PHARMACEUTICAL CO LTD-0.17%29 185
ASTELLAS PHARMA INC-0.97%26 821
Connections : Amgen
Los Angeles Philharmonic Association
FdeC Services Ltd.
Cardax Pharma, Inc.
Ecofin Hedge Fund Ltd.
California Pacific Medical Center Foundation
National Bureau of Economic Research, Inc.
The Minnesota Opera Co.
BioVex Group, Inc.
Aegon U.S. Corp.
Ecofin Special Situations Funds Ltd.
Tuck School of Business at Dartmouth
Business & Environment Initiative
Charles Schwab Bank
Pearl Harbor Memorial Fund
Human Genome Organisation
The Column Group LLC
Onyx Pharmaceuticals, Inc.
Woodside Holdings Investment Management Pte Ltd.
Calimmune, Inc.
Groupe Foncier de l'Ile de France SA
Amgen Rockville, Inc.
Parc des Aulnais SA
University of Southern California
CEO Roundtable on Cancer, Inc.
UCLA Anderson School of Management
Harvard University
Pharmaceutical Research & Manufacturers of America
Harvard Business School
The Broad Institute, Inc.
BeyondTrust Software, Inc.
The Damon Runyon Cancer Research Foundation
Boys & Girls Clubs of America
Foundation for Biomedical Research
FasterCures
Alliance College-Ready Public Schools
The Broad Foundations
National Academy of Engineering
© 2018 People , Fundamentals and Ownership    © 2018 Cofisem